Generation Lab Raises $11M Seed Round for Longevity Science

Why It Matters

The infusion of $11 million validates market confidence in longevity therapeutics and could accelerate the development of breakthrough anti‑aging treatments, positioning Generation Lab to compete in a rapidly expanding biotech segment.

Deal Summary

Generation Lab announced the completion of an $11 million seed funding round to advance its longevity science breakthroughs. The round was disclosed in a company announcement dated on the article.